Padeliporfin potassium by ImPact Biotech for Esophageal Cancer: Likelihood of Approval

Padeliporfin potassium is under clinical development by ImPact Biotech and currently in Phase I for Esophageal Cancer.

MedPAC Tackles Accuracy of Medicare Advantage Network Directories

Inaccuracies in Medicare Advantage (MA) directories listing in-network providers — often criticized as being too “narrow” — and flaws in rules governing them need to

November 9, 2024

Weekly Ozempic/Wegovy Injections May Lower Kidney Failure Risk

What You Should Know: – A new study suggests that a weekly treatment with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly reduce the

May 29, 2024

April 2024 starts the legalization of cannabis in Germany, enormous potential for sales and growth – Biotech Investments

EQS-News: Cannovum Cannabis AG / Key word(s): Forecast/Expansion Cannovum Cannabis AG: April 2024 starts the legalization of cannabis in Germany, enormous potential for sales and

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.